Rare & Potentially Deadly Fungus Seen in a Few Recovered COVID-19 Patients Nose and Jawbone Removal

 

Doctors treating COVID-19 patients at New Delhi’s Sir Ganga Ram Hospital have reported that over a dozen of these recovered patients went on to develop a serious fungal infection and five of them lost their lives.

The fungus can lead to various gruesome outcomes, depending on where it might spread in the body. In some cases, the infection could necessitate the removal of the nose and jawbone and can also cause permanent loss of eyesight.

The fungus seems to exploit the immune system’s Cytokine response, which is provoked by the huge doses of steroids used for the treatment of the coronavirus.

 

“It allows mucormycosis to travel through the nose root to the eyes and brain and, if undetected, it can lead to the death of over 50 percent cases in a matter of days.” Dr. Manish Munjal, Ganga Ram’s senior ENT surgeon told ANI.

 

Dr. Atul Patel, a leading Indian infectious diseases expert said that 19 cases of mucormycosis  recorded in the past three months, among recovered COVID-19 patients, is a significant spike.

 

“This is 4.5 times higher than the burden reported conventionally before the pandemic,” Patel said.

 

He added, “This is a serious issue and healthcare providers should be extremely cautious.”

 

The fungal infection has to be diagnosed immediately, so that clinical intervention can take place and a viable treatment can be put in place.

 

According to the US Centers for Disease Control and Prevention symptoms include one-sided facial swelling, fever and headaches. Nasal congestion and the appearance of growing black spots inside the mouth or on the nose are other symptoms.


Follow us on Google news for more updates and News










PLEASE READ THE IMPORTANT DISCLOSURES BELOW.

This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.